Matthew R Cooperberg

Sloan-Kettering Inst Can Research

$4,615,223

Attributed

$6,098,495

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY2012–25

$2M$1.5M$1M$500K$0

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,098,495 · 4

By mechanism

R01$5,653,518 · 3

U54$444,977 · 1

Top collaborators

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Amita Dave$3,998,296
Jennifer Cf Leng$9,013,476
Hans-Guido Wendel$13,517,904
Brian Matthew Zeglis$6,881,872
Hans Gãsta Lilja$2,754,869

Others in their field

Top investigators on “Malignant Neoplasm Of Prostate”

David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
Walter John Curran · Thomas Jefferson University$61,298,085
Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
James J. Dignam · University Of Chicago$48,310,409
Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962

Research focus

Malignant Neoplasm Of ProstateCohortValidationSamplingAffectMalignant NeoplasmsProstateBloodBiopsySerumScreening For Prostate CancerBaseProstatectomyDiagnosisPathologyTissuesInsightBiological MarkersGenomicsProstate-Specific AntigenTumorProstate BiopsyPatient SubsetsPrognostic